See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2022_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 172,606,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 50,414,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,636,000 |
| 3 | remainder_Assets | 29,076,000 |
| 4 | LiabilitiesCurrent | 74,376,000 |
| 5 | LiabilitiesNoncurrent | 2,903,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 31,576,857 |
| 8 | SellingGeneralAndAdministrativeExpense | 73,009,190 |
| 9 | ResearchAndDevelopmentExpense | 50,011,515 |
| 10 | remainder_Expenses | 15,579,260 |
| 11 | remainder_Revenues | 149,316,762 |
| 12 | remainder_NetIncome | -8,363,766 |
| 13 | remainder_ComprehensiveNetIncome | -94,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 253,732,000 |
| 1 | Liabilities | 77,279,000 |
| 2 | Expenses | 170,176,822 |
| 3 | Revenues | 149,316,762 |
| 4 | StockholdersEquity | 176,453,000 |
| 5 | NetIncome | -29,223,826 |
| 6 | ComprehensiveNetIncome | -29,270,826 |
| 7 | BaseVar | 329,481,175 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.15 |
| 9 | EconomicCapitalRatio | 3.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
